Literature DB >> 24622790

First fully automated immunoassay for anti-Müllerian hormone.

Dieter Gassner, Rebecca Jung.   

Abstract

BACKGROUND: The increasing importance of anti-Müllerian hormone (AMH) for the assessment of ovarian reserve requires accurate AMH measurements. There have been conflicting results about the reliability of currently existing manual AMH assays.
METHODS: Development of a high sensitive, fast and fully automated AMH assay on the Elecsys®/cobas e electrochemiluminescence immunoassay platform.
RESULTS: Elecsys® AMH is a monoclonal two-site assay used to measure AMH in 50 µL of serum or lithium heparin plasma in about 18 min. Its measuring range is from 0.01 to 23 ng/mL. The assay detects primarily 140 kDa total AMH (proAMH and AMHN,C). Standardization was against the Beckman AMH Gen II. Recovery against the highly cited Immunotech calibration was about 90%. Within-run imprecision coefficient of variation (CV) calculated on 10 serum samples were between 0.5% and 1.8%. Repeatability and intermediate precision calculated on 14 serum samples ranged from 2.6% to 1.7% and 2.9% to 2.1%, respectively. Limit of detection (LoD) [limit of quantitation (LoQ)] was 0.01 ng/mL (0.03 ng/mL). Percent recovery in dilution studies was <10% and after mixing of high and low AMH pools 94% to 103%. Elecsys® AMH, when compared to revised AMH Gen II (or Ansh Labs ultrasensitive AMH ELISA) using 57 female serum samples yielded a correlation coefficient of 0.98 (0.97) and a slope of 0.81 (0.73). There was no evidence for sample instability or variability. Samples stored at 20-25 °C or 2-8 °C up to 7 days showed no significant storage issues. Freeze-thaw cycles or sample storage at -20 °C and -80 °C for up to 9 months was without any effect on measured AMH.
CONCLUSIONS: Availability of an automated Elecsys® AMH assay offers an attractive alternative to the current manual AMH assays.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24622790     DOI: 10.1515/cclm-2014-0022

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  32 in total

1.  Anti-Müllerian hormone in pre-menopausal females after ablative radioiodine treatment for differentiated thyroid cancer.

Authors:  Massimo Giusti; Miranda Mittica; Paola Comite; Claudia Campana; Stefano Gay; Michele Mussap
Journal:  Endocrine       Date:  2018-01-04       Impact factor: 3.633

2.  Live Birth Rates in Women Under 38 Years Old with AMH Level < 1.2 ng/ml in the First In Vitro Fertilization + / - Intracytoplasmic Sperm Injection: Retrospective Study and Arguments for Care.

Authors:  Karine Morcel; Philippe Merviel; Diane Pertuisel; Pandora James; Sarah Bouée; Mathilde Le Guillou; Jean-Jacques Chabaud; Sylvie Roche; Hortense Drapier; Aurore Perrin; Damien Beauvillard
Journal:  Reprod Sci       Date:  2022-09-29       Impact factor: 2.924

3.  Reliability of AMH and AFC measurements and their correlation: a large multicenter study.

Authors:  Philippe Arvis; Catherine Rongières; Olivier Pirrello; Philippe Lehert
Journal:  J Assist Reprod Genet       Date:  2022-03-03       Impact factor: 3.357

Review 4.  Elecsys(®) AMH Assay: A Review in Anti-Müllerian Hormone Quantification and Assessment of Ovarian Reserve.

Authors:  Emma D Deeks
Journal:  Mol Diagn Ther       Date:  2015-08       Impact factor: 4.074

5.  Comparison of two different methods for measuring anti-mullerian hormone in a clinical series.

Authors:  Josephine Hyldgaard; Pinar Bor; Hans Jakob Ingerslev; Niels Tørring
Journal:  Reprod Biol Endocrinol       Date:  2015-09-22       Impact factor: 5.211

Review 6.  Fertility in women of late reproductive age: the role of serum anti-Müllerian hormone (AMH) levels in its assessment.

Authors:  B Meczekalski; A Czyzyk; M Kunicki; A Podfigurna-Stopa; L Plociennik; G Jakiel; M Maciejewska-Jeske; K Lukaszuk
Journal:  J Endocrinol Invest       Date:  2016-06-14       Impact factor: 4.256

7.  Evaluation of a new automated immunoassay for the quantification of anti-Müllerian hormone.

Authors:  Manuela Lotierzo; Victor Urbain; Anne-Marie Dupuy; Jean-Paul Cristol
Journal:  Pract Lab Med       Date:  2021-04-14

Review 8.  Challenges in Measuring AMH in the Clinical Setting.

Authors:  Hang Wun Raymond Li; David Mark Robertson; Chris Burns; William Leigh Ledger
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-24       Impact factor: 5.555

Review 9.  Maximizing the clinical utility of antimüllerian hormone testing in women's health.

Authors:  Benjamin Leader; Valerie L Baker
Journal:  Curr Opin Obstet Gynecol       Date:  2014-08       Impact factor: 1.927

10.  Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations.

Authors:  Kelly-Anne Phillips; Ian M Collins; Roger L Milne; Sue Anne McLachlan; Michael Friedlander; Martha Hickey; Catharyn Stern; John L Hopper; Richard Fisher; Gordon Kannemeyer; Sandra Picken; Charmaine D Smith; Thomas W Kelsey; Richard A Anderson
Journal:  Hum Reprod       Date:  2016-05       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.